GRI GRI Bio Inc

Price (delayed)

$2.15

Market cap

$4.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$15.12

Enterprise value

-$6.2M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are designed to target the activity of ...

Highlights
GRI Bio's debt has plunged by 54% YoY and by 24% from the previous quarter
The net income has grown by 11% from the previous quarter and by 3.5% YoY
GRI Bio's EPS has plunged by 114% YoY but it has soared by 70% from the previous quarter
GRI's quick ratio is down by 28% QoQ
The equity has contracted by 2.5% from the previous quarter

Key stats

What are the main financial stats of GRI

GRI stock price

How has the GRI Bio stock price performed over time
Intraday
4.88%
1 week
18.78%
1 month
30.3%
1 year
-96.06%
YTD
-68.89%
QTD
21.47%

Financial performance

How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.68M
Net income
-$9.66M
Gross margin
N/A
Net margin
N/A
GRI Bio's operating income has increased by 11% from the previous quarter and by 3.5% YoY
The net income has grown by 11% from the previous quarter and by 3.5% YoY

Price vs fundamentals

How does GRI's price correlate with its fundamentals

Growth

What is GRI Bio's growth rate over time

Valuation

What is GRI Bio stock price valuation
P/E
N/A
P/B
0.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has plunged by 114% YoY but it has soared by 70% from the previous quarter
The price to book (P/B) is 96% lower than the 5-year quarterly average of 9.9 and 61% lower than the last 4 quarters average of 0.9
The equity has contracted by 2.5% from the previous quarter

Efficiency

How efficient is GRI Bio business performance
GRI's ROE has soared by 66% YoY and by 33% QoQ
The company's return on assets has surged by 53% YoY and by 25% QoQ

Dividends

What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRI.

Financial health

How did GRI Bio financials performed over time
GRI's total assets has soared by 101% YoY
GRI's total liabilities has dropped by 53% year-on-year but it is up by 39% since the previous quarter
GRI Bio's debt is 100% less than its equity
GRI's debt to equity has plunged by 100% from the previous quarter and by 100% YoY
GRI Bio's debt has plunged by 54% YoY and by 24% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.